← back to search

Charalambos Vlachopoulos

Hellenic Cardiological Society · GR
Area of research
Cardiology and Cardiovascular Medicine · Endocrinology, Diabetes and Metabolism
Research interest
Research interests include Cardiovascular Health and Disease Prevention, Blood Pressure and Hypertension Studies, Cardiovascular Disease and Adiposity, and Hormonal and reproductive studies.
h-index
75
citations
46,608
works
672
NIH funding
primary concept
email

Recent publications

QTc interval prolongation as a marker of disease stage in transthyretin cardiac amyloidosis.
2026cited by 1position: contributordoi
Fast & furious: the acceleration of randomized clinical trials in contemporary cardiovascular medicine.
2026cited by 0position: contributordoi
Human intravenous immunoglobulins: a promising treatment for recurrent pericarditis.
2026cited by 0position: contributordoi
Medicine shapes ethics; however, it has to be the other way round as well.
2026cited by 0position: contributordoi
Publisher Correction: QTc interval prolongation as a marker of disease stage in transthyretin cardiac amyloidosis.
2026cited by 0position: contributordoi
Decoding the Heart Through Computed Tomography: Early Cardiomyopathy Detection Using Ensemble-Based Segmentation and Radiomics.
2026cited by 0position: contributordoi
Temporal Variability of ECG Risk Markers and Clinical Outcomes in Non-Dilated Left Ventricular Cardiomyopathy.
2026cited by 0position: contributordoi
Lipoprotein(a) as a Stroke Biomarker: Pathophysiological Pathways and Therapeutic Implications.
2025cited by 7position: contributordoi
Ageism in medicine: procrustean logic in healthcare
Hellenic Journal of Cardiology 2025cited by 1position: contributordoi
Shocking and inhumane inequalities. The gender gaps in Cardiology.
2025cited by 1position: contributordoi
Cardiac Magnetic Resonance to Reclassify Diagnosis and Detect Cardiomyopathies in Hospitalized Patients with Acute Presentation.
2025cited by 1position: contributordoi
Exploring the Current Status of Risk Stratification in Hypertrophic Cardiomyopathy: From Risk Models to Promising Techniques.
2025cited by 1position: contributordoi
To implement or to innovate? Which is the noble action for the future in heart failure.
2025cited by 0position: contributordoi
Mind the gap: the silent divide of digital health (Il)literacy.
2025cited by 0position: contributordoi
Effects of Athletic Nutritional Supplements on the Human Gut Microbiota: A Narrative Review.
2025cited by 0position: contributordoi
Myocardial Fibrosis in Athletes: Risk Marker or Physiological Adaptation?
2025cited by 0position: contributordoi
Cardiac Magnetic Resonance to Reclassify Diagnosis and Detect Cardiomyopathies in Hospitalized Patients with Acute Presentation
2025cited by 0position: contributordoi
Vascular-related cone-beam computed tomographic findings in healthy and medically compromised patients: A study based on self-reported medical history data.
2025cited by 0position: contributordoi
Anabolic-Androgenic Steroids Induced Cardiomyopathy: A Narrative Review of the Literature.
2025cited by 0position: contributordoi
Beyond lipid levels: unraveling the hypertensive factor in familial hypercholesterolemia. The HELLAS-FH registry.
2025cited by 0position: contributordoi
2024 Recommendations for Validation of Noninvasive Arterial Pulse Wave Velocity Measurement Devices.
2024cited by 44position: contributordoi
Tenecteplase for the treatment of acute ischemic stroke in the extended time window: a systematic review and meta-analysis
Therapeutic Advances in Neurological Disorders 2024cited by 20position: middledoi
Long-term effects of phosphodiesterase-5 inhibitors on cardiovascular outcomes and death: a systematic review and meta-analysis.
2024cited by 14position: contributordoi
Imagenetics for Precision Medicine in Dilated Cardiomyopathy.
2024cited by 11position: contributordoi
Interleukin-1 Blockers: A Paradigm Shift in the Treatment of Recurrent Pericarditis.
2024cited by 7position: contributordoi
Prevalence and Risk Factors for Atherosclerotic Cardiovascular Disease in 7704 Individuals: An Analysis from the Greek Registry for the Prevalence of Familial Hypercholesterolemia (GRegistry-FH).
2024cited by 2position: contributordoi
Progression of subclinical atherosclerosis in ankylosing spondylitis: a 10-year prospective study.
2024cited by 2position: contributordoi
Clinical practice guidelines are the worst guidance there is.
2024cited by 1position: contributordoi
Asymptomatic Chronic Large Pericardial Effusions: To Drain or to Observe?
2024cited by 1position: contributordoi
Prognostic Role of Functional SYNTAX Score Based on Quantitative Flow Ratio.
2024cited by 1position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 52 papers (2020–2026)Konstantinos Tsioufis · Hellenic Air Force9 papers (2021–2026)George Lazaros · Hippocration General Hospital9 papers (2021–2025) · 9 papers (2021–2024)Alexandros Kasiakogias · St George's, University of London6 papers (2024–2025)Alexis Antonopoulos · Fondazione Toscana Gabriele Monasterio4 papers (2021–2026)Vasiliki Gardikioti · Springer Nature4 papers (2020–2024)Anastasia Xintarakou · Elsevier, Inc.4 papers (2023–2026)Graham Jackson · St Thomas' Hospital3 papers (2012–2013)Peter Ganz · Chan Zuckerberg Initiative (United States)3 papers (2012–2013)Thomas Weber · Siemens Healthcare (Germany)3 papers (2015–2023) · 3 papers (2012–2013) · 3 papers (2012–2013)Allen D. Seftel · Allen Institute3 papers (2012–2013)Ajay Nehra · Rush University Medical Center3 papers (2012–2013) · 3 papers (2021–2022)Konstantinos Aznaouridis · Elsevier, Inc.3 papers (2022–2024)Ioanna Dima · General-Maternity District Hospital Helena Venizelou3 papers (2020–2025) · 3 papers (2023–2026)Stergios Soulaidopoulos · Elsevier, Inc.3 papers (2021–2024)